Weight loss is one of the few factors that have consistently been shown to be associated with shortened survival in people with lymphoma. This study aims to document how often dogs experience weight loss or decrease in muscle mass at the time that lymphoma is diagnosed, and whether this finding impacts how dogs respond to treatment.
Dogs with multicentric lymphoma that have undergone full staging.
Prior chemotherapy (including prednisone) or dogs with lymphoma within the gastrointestinal tract.
Kelly Reed, Oncology Liaison
Phone: (508) 887-4682